Paid Clinical Trials Paid Clinical Trials > Browse Categories > Medications / Interventions > Ee > Ebselen

Ebselen

Ebselen

All Categories Medications / Interventions » Ee » Ebselen


  • SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

    Conditions:   Lung Cancer;   Head and Neck Cancer;   Hearing Loss;   Ototoxicity;   Tinnitus;   Neuropathy
    Interventions:   Drug: SPI-1005 Low Dose;   Drug: SPI-1005 Middle dose;   Drug: SPI-1005 High Dose;   Drug: Placebo
    Sponsors:   Sound Pharmaceuticals, Incorporated;   Sound Pharmaceuticals, Incorporated;   VA Puget Sound Health Care System
    Not yet recruiting - verified October 2011
  • Otoprotection With SPI-1005

    Condition:   Temporary Auditory Threshold Shift
    Interventions:   Drug: SPI-1005 Low dose;   Drug: SPI-1005 Middle dose;   Drug: SPI-1005 High dose;   Drug: Placebo
    Sponsors:   Sound Pharmaceuticals, Incorporated;   Sound Pharmaceuticals, Incorporated;   University of Florida
    Recruiting - verified October 2011

Main Menu
Clinical Trial Categories
Clinical Trial Locations